2005
DOI: 10.1097/00000542-200510000-00011
|View full text |Cite|
|
Sign up to set email alerts
|

AQUAVAN® Injection, a Water-soluble Prodrug of Propofol, as a Bolus Injection: A Phase I Dose-escalation Comparison with DIPRIVAN® (Part 2): Pharmacodynamics and Safety: Retracted

Abstract: Bolus administration of AQ achieves LOCverbal at a similar time as an equipotent amount of PropofolD but shows a longer time to BISpeak and prolonged pharmacodynamics. For both drugs, excellent drug safety was achieved, although there was a tendency of fewer and shorter duration of apneas for AQ.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
32
0
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(36 citation statements)
references
References 19 publications
(21 reference statements)
3
32
0
1
Order By: Relevance
“…In summary, GPI 15715 or fospropofol has been extensively studied in human volunteers. The pharmacokinetic differences for propofol G we found are in agreement with the results of other study groups Struys et al 2005), but the higher pharmacodynamic potency of propofol G compared to propofol L that we found has not been proved in other investigations.…”
Section: Summary Of Published Study Results Of Gpi 15715 or Fospropofolsupporting
confidence: 87%
See 1 more Smart Citation
“…In summary, GPI 15715 or fospropofol has been extensively studied in human volunteers. The pharmacokinetic differences for propofol G we found are in agreement with the results of other study groups Struys et al 2005), but the higher pharmacodynamic potency of propofol G compared to propofol L that we found has not been proved in other investigations.…”
Section: Summary Of Published Study Results Of Gpi 15715 or Fospropofolsupporting
confidence: 87%
“…Besides the studies presented above, which were the first two investigating possible PK/PD differences after infusion and TCI-infusion of GPI 15715 or fospropofol in volunteers (Fechner et al 2004;Fechner et al 2003), two other combined studies presenting the PK/PD results after bolus dosing of GPI 15715 or fospropofol compared to lipid-formulated propofol in human volunteers have been published Struys et al 2005). They found a combined pharmacokinetic model with three compartments for GPI 15715 and three compartments for propofol G best described their data.…”
Section: Summary Of Published Study Results Of Gpi 15715 or Fospropofolmentioning
confidence: 99%
“…Međutim, samo je fospropofol dinatrijum odobren za korišcenje od strane Američke agencije za hranu i lekove 6 . Fospropofol izaziva manji lokalni bol prilikom aplikacije 16 . Ondansetron je poznat kao centralni antiemetik i najčešće se koristi kod postoperativne mučni-ne i povraćanja.…”
Section: Uvodunclassified
“…Fospropofol disodium (Aquavan Injection) is a novel sedative/hypnotic, water-soluble prodrug of propofol with pharmacokinetic and pharmacodynamic properties that differ from those of propofol emulsion [62][63][64]. Aquavan is hydrolyzed by alkaline phosphatase to release propofol [62][63][64][65].…”
Section: New Concepts In Sedation For Colonoscopymentioning
confidence: 99%
“…Aquavan is hydrolyzed by alkaline phosphatase to release propofol [62][63][64][65]. The pharmacokinetic profile of Aquavan is characterized by avoidance of the high peak plasma concentrations seen with the lipid emulsion formulation of propofol (Fig.…”
Section: New Concepts In Sedation For Colonoscopymentioning
confidence: 99%